Navigation Links
GeneCards® Version 3.07 Released

CAMBRIDGE, Mass., Nov. 14, 2011 /PRNewswire/ -- Xennex Inc. (Xennex) announced today the release of GeneCards®, Version 3.07, available at

The new GeneCards release includes 68,445 Entries, 32,088 of them with symbols approved by the HUGO gene nomenclature committee. It provides several new features, integrated from a variety of sources, including:

Ensembl Pan Taxonomic Compara: Orthologs from non-eukaryotic domains were added in the Orthologs section.

STRING: New Interaction Network Preview image in the Pathways and Interactions section.

MGI: New direct listing for mouse knockouts in the Function section.

GeneALaCart: Various new features including microRNAs and bound targets have been added to the Function section, the Pathways and Interactions section, the Orthologs section, and the Genomic Variants section.

New links to Cell Lines in the Function section, custom synthetic genes, with links to Protein Engineering Gene Synthesis and Variant Synthesis, in the Function, Transcripts, and Genomic Variants sections. New links to Small Molecules in the Drugs and Compounds section, ELISAs and Cell Lines in the Proteins and Function sections, QuantiFast Probe-based Assays in the Transcripts and Expression sections and new Pathways in the Pathways and Interactions section.

In 2010, GeneCards Version 3.0 replaced the previous platform, incorporating significantly upgraded infrastructure, including a comprehensive relational biological database, and a novel, sophisticated and speedier search engine. It includes GeneALaCart, a batch-querying application that allows retrieval of information about multiple genes in a batch query, and an enhanced GeneDecks Version 3, which makes use of the new GeneCards relational database for complex analyses on sets of genes. With GeneCards Version 3.0, Xennex's customers are able to integrate GeneCards data into their internal systems, and perform comprehensive data mining. These features are also described in Safran et al. GeneCards Version 3: the human gene integrator. Two other recent publications describing GeneCards features include Stelzer et al. In-silico Human Genomics with GeneCards, as well as Harel et al. Omics Data Management and Annotation, Chapter 3. These, and a complete list of 28 GeneCards publications, can be found via

Dr. David Warshawsky, Chairman of Xennex, stated: "We are delighted to see the continued improvement GeneCards features and content utilizing the 3.0. platform. This platform received very positive feedback from existing and new users in academia and industry. Ongoing GeneCards improvement continues to enhance the cutting-edge research in various fields of biology and medicine, and in the discovery and development of diagnostics and therapeutics."

About GeneCards®

GeneCards® ( is a searchable, integrated, database of human genes that provides concise genomic, transcriptomic, genetic, proteomic, functional and disease related information on all known and predicted human genes. Information is featured in 20 GeneCards sections and includes orthologies, disease relationships, mutations and SNPs, gene expression, gene function, pathways, protein-protein interactions, related drugs & compounds and direct links to valuable research reagents and tools such as antibodies, recombinant proteins, clones, expression assays and RNAi reagents. GeneCards was developed over the last 14 years by a world-leading bioinformatics team at the Weizmann Institute of Science in Israel, directed by Marilyn Safran and under the principal investigation of Professor Doron Lancet of the Department of Molecular Genetics, Head of the Crown Human Genome Center, and the incumbent of the Ralph & Lois Silver Professorial Chair of Human Genomics at the Weizmann Institute of Science.

About Xennex  

Founded in 2003, Xennex, Inc. ( is a dynamic privately held company that is dedicated to providing Biotechnology, Pharmaceutical and other life sciences companies, as well as organizations dealing with biotechnology intellectual property, the highest level of services and tools to enhance their gene-based research. Xennex's products help such organizations to optimize their efforts to develop innovative medical products and services.

Xennex's customers include many of the world's leading biotech and pharmaceutical companies and organizations dealing with intellectual property, located in North America, Europe and Japan. Xennex's products are used in hundreds of commercial and academic organizations by tens of thousands of users around the globe.

For further information, please contact:

Xennex Inc.
Kenneth Elsner
Director of US operations and CFO
Tel: +1 781 826 7719 (USA)

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at

SOURCE Xennex Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Perrigo Announces Launch of Generic Version of Elestat®
2. Mylan Receives Approval for Generic Version of MS Contin® Tablets
3. Mylan Launches First Generic Version of Exelon® Capsules in the U.K.
4. Watson Provides Update on District Court Order Concerning Generic Version of LOVENOX®
5. Watson Confirms District Court Order Concerning Generic Version of LOVENOX(R)
6. Sysmex Announces Newest Version of Clinical Laboratory Management Software
7. Mylans Matrix Receives Tentative FDA Approval Through PEPFAR for Novel "Co-Packaged" Version of HIV/AIDS Treatment
8. PDL BioPharma Announces Conversion Rate Adjustments for Its Convertible Notes
9. Medicomp Releases ICD-10-CM with New Version of the Powerful MEDCIN Engine®
10. Mylan Launches Generic Version of Uroxatral® Tablets
11. Hospira Announces U.S. Approval of Solution Version of Gemcitabine Injection
Post Your Comments:
(Date:11/24/2015)... 24, 2015 Teledyne DALSA , a Teledyne ... technology, will introduce its CMOS X-Ray detector for mammography ... 29 to December 3, at McCormick Place in ... diagnostic and interventional imaging will be on display in the ... of advanced CMOS X-Ray detectors is the industry benchmark for ...
(Date:11/24/2015)... , Nov. 24, 2015  Enova Illumination is ... of Helsinki, Finland to combine ... are at the cutting edge of medical visualization: Enova ... the United States and Novocam ... Together, they provide the world,s most powerful battery-operated LED ...
(Date:11/24/2015)... Nov. 24, 2015  Freudenberg Medical has developed specialty tubing ... outside of medical facilities. Africa ... care is sparse. Nevertheless, prompt diagnosis is important to treat ... the virus. With the help of a portable mini-lab or ... to village in affected areas and perform rapid testing for ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... November 24, 2015 , ... Dehydration, defined as a loss ... to perspiration in the hot sun, and heat stroke and death will quickly follow. ... radio host Sharon Kleyne. Every cell, system and structure requires water to function properly. ...
(Date:11/24/2015)... ... 2015 , ... “I am so thrilled, as a newbie here, to leave a mark for ... $7,500 School Lounge Makeover® from California Casualty . Stephanie is in her fifth year ... much longer tenure. , “This is such an amazing school and we deserve a space ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... and safety labels , has been featured in the American Feed ... exclusively to representing the business, legislative and regulatory interests of the U.S. animal ...
(Date:11/24/2015)... ... ... Add a fresh touch to this year’s holiday festivities with indoor plants ... style and cheer to any space. , Holiday plants are more than just festive ... all year long. , “Holiday plants make a room come alive,” says Justin Hancock, ...
(Date:11/24/2015)... ... , ... On the pleasant autumn morning of November 15, 2015, nearly 130 ... for Autism held at Steep Rock Preserve in Washington, Connecticut. The run, which offers ... triumph. , Created and hosted by The Glenholme School, a special needs boarding and ...
Breaking Medicine News(10 mins):